Severe mental illness: cardiovascular risk assessment and management

被引:13
作者
Polcwiartek, Christoffer [1 ]
O'Gallagher, Kevin [2 ,3 ]
Friedman, Daniel J. [4 ]
Correll, Christoph U. [5 ,6 ,7 ,8 ,9 ]
Solmi, Marco [8 ,10 ,11 ,12 ,13 ]
Jensen, Svend Eggert [1 ,14 ]
Nielsen, Rene Ernst [14 ,15 ]
机构
[1] Aalborg Univ Hosp, Dept Cardiol, Hobrovej 18-22, DK-9000 Aalborg, Denmark
[2] Kings Coll Hosp NHS Fdn Trust London, Cardiovasc Dept, London, England
[3] Kings Coll London, British Heart Fdn Ctr Res Excellence, Sch Cardiovasc & Metab Med & Sci, London, England
[4] Duke Univ, Med Ctr, Sect Cardiac Electrophysiol, Durham, NC USA
[5] Zucker Hillside Hosp, Northwell Hlth, Dept Psychiat, Glen Oaks, NY USA
[6] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Psychiat & Mol Med, Hempstead, NY USA
[7] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Northwell Hlth, New Hyde Pk, NY USA
[8] Charite Univ Med Berlin, Dept Child & Adolescent Psychiat, Berlin, Germany
[9] German Ctr Mental Hlth, DZPG, Partner Site Berlin, Berlin, Germany
[10] Univ Ottawa, Dept Psychiat, Ottawa, ON, Canada
[11] Ottawa Hosp, Reg Ctr Treatment Eating Disorders, Dept Mental Hlth, Ottawa, ON, Canada
[12] Ottawa Hosp, Dept Mental Hlth, Track Champlain Episode Psychosis Program 1, Ottawa, ON, Canada
[13] Univ Ottawa, Ottawa Hosp Res Inst OHRI, Clin Epidemiol Program, Ottawa, ON, Canada
[14] Aalborg Univ, Dept Clin Med, Aalborg, Denmark
[15] Aalborg Univ Hosp, Psychiat, Aalborg, Denmark
关键词
Severe mental illness; Cardiovascular disease; Risk factors; Screening; Cardiovascular mortality; Sudden cardiac death; Risk stratification; SCHIZOPHRENIA SPECTRUM DISORDERS; BIPOLAR DISORDER; PRIMARY-CARE; MYOCARDIAL-INFARCTION; CARDIOMETABOLIC RISK; PHYSICAL HEALTH; MORTALITY GAP; PEOPLE; DISEASE; METAANALYSIS;
D O I
10.1093/eurheartj/ehae054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with severe mental illness (SMI) including schizophrenia and bipolar disorder die on average 15-20 years earlier than the general population often due to sudden death that, in most cases, is caused by cardiovascular disease. This state-of-the-art review aims to address the complex association between SMI and cardiovascular risk, explore disparities in cardiovascular care pathways, describe how to adequately predict cardiovascular outcomes, and propose targeted interventions to improve cardiovascular health in patients with SMI. These patients have an adverse cardiovascular risk factor profile due to an interplay between biological factors such as chronic inflammation, patient factors such as excessive smoking, and healthcare system factors such as stigma and discrimination. Several disparities in cardiovascular care pathways have been demonstrated in patients with SMI, resulting in a 47% lower likelihood of undergoing invasive coronary procedures and substantially lower rates of prescribed standard secondary prevention medications compared with the general population. Although early cardiovascular risk prediction is important, conventional risk prediction models do not accurately predict long-term cardiovascular outcomes as cardiovascular disease and mortality are only partly driven by traditional risk factors in this patient group. As such, SMI-specific risk prediction models and clinical tools such as the electrocardiogram and echocardiogram are necessary when assessing and managing cardiovascular risk associated with SMI. In conclusion, there is a necessity for differentiated cardiovascular care in patients with SMI. By addressing factors involved in the excess cardiovascular risk, reconsidering risk stratification approaches, and implementing multidisciplinary care models, clinicians can take steps towards improving cardiovascular health and long-term outcomes in patients with SMI. Graphical Abstract The increased risk of cardiovascular disease associated with severe mental illness (SMI) is multifactorial and driven by complex pathways. Patients with SMI have a high burden of cardiovascular risk factors and disease, and a major challenge in clinical practice is that these patients tend to neglect cardiovascular symptoms, healthcare professionals often overlook and misinterpret cardiovascular signs and symptoms of patients, patients are less likely to receive timely and proper cardiovascular care, and treatment adherence is reduced in these patients. Consequently, patients with SMI develop significantly earlier atherosclerotic cardiovascular disease and therefore require intensive primary prevention strategies that include a more aggressive approach to management of cholesterol levels, blood pressure, and other cardiovascular risk factors.
引用
收藏
页码:987 / 997
页数:11
相关论文
共 118 条
  • [51] Increased long-term mortality after myocardial infarction in patients with schizophrenia
    Kugathasan, Pirathiv
    Laursen, Thomas Munk
    Grontved, Simon
    Jensen, Svend Eggert
    Aagaard, Jorgen
    Nielsen, Rene Ernst
    [J]. SCHIZOPHRENIA RESEARCH, 2018, 199 : 103 - 108
  • [52] Poor monitoring of physical health in patients referred to a mood disorders service
    Lack, David
    Holt, Richard I. G.
    Baldwin, David S.
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2015, 5 (01) : 22 - 25
  • [53] Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study
    Laursen, T. M.
    Mortensen, P. B.
    MacCabe, J. H.
    Cohen, D.
    Gasse, C.
    [J]. PSYCHOLOGICAL MEDICINE, 2014, 44 (08) : 1625 - 1637
  • [54] Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
    Libby, Peter
    Tabas, Ira
    Fredman, Gabrielle
    Fisher, Edward A.
    [J]. CIRCULATION RESEARCH, 2014, 114 (12) : 1867 - 1879
  • [55] Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]
  • [56] Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
    Magnussen, Christina
    Ojeda, Francisco M.
    Leong, Darryl P.
    Alegre-Diaz, Jesus
    Amouyel, Philippe
    Aviles-Santa, Larissa
    De Bacquer, Dirk
    Ballantyne, Christie M.
    Bernabe-Ortiz, Antonio
    Bobak, Martin
    Brenner, Hermann
    Carrillo-Larco, Rodrigo M.
    de Lemos, James
    Dobson, Annette
    Dorr, Marcus
    Donfrancesco, Chiara
    Drygas, Wojciech
    Dullaart, Robin P.
    Engstrom, Gunnar
    Ferrario, Marco M.
    Ferrieres, Jean
    de Gaetano, Giovanni
    Goldbourt, Uri
    Gonzalez, Clicerio
    Grassi, Guido
    Hodge, Allison M.
    Hveem, Kristian
    Iacoviello, Licia
    Ikram, M. Kamran
    Irazola, Vilma
    Jobe, Modou
    Jousilahti, Pekka
    Kaleebu, Pontiano
    Kavousi, Maryam
    Kee, Frank
    Khalili, Davood
    Koenig, Wolfgang
    Kontsevaya, Anna
    Kuulasmaa, Kari
    Lackner, Karl J.
    Leistner, David M.
    Lind, Lars
    Linneberg, Allan
    Lorenz, Thiess
    Lyngbakken, Magnus Nakrem
    Malekzadeh, Reza
    Malyutina, Sofia
    Mathiesen, Ellisiv B.
    Melander, Olle
    Metspalu, Andres
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (14) : 1273 - 1285
  • [57] Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
    Mangurian, Christina
    Giwa, Aishat
    Brosey, Erin
    Shumway, Martha
    Dilley, James
    Fuentes-Afflick, Elena
    Perez-Stable, Eliseo J.
    Schillinger, Dean
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2019, 32 (03) : 418 - +
  • [58] MARCHAND WE, 1955, NEW ENGL J MED, V253, P51
  • [59] Schizophrenia
    Marder, Stephen R.
    Cannon, Tyrone D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18) : 1753 - 1761
  • [60] Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
    Maury, E.
    Brichard, S. M.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 314 (01) : 1 - 16